Fotona Aesthetic Lasers: FDA Clearance Footprint and MAUDE Safety Profile

Fotona holds 38 FDA 510(k) clearances under applicant Fotona, all filed under the product code GEX (Powered Laser Surgical Instrument). Spanning from March 27, 1998 (K980560, Fotona SkinPlus Laser System) through August 23, 2024 (K242202, LightWalker Laser System Family), Fotona’s cleared systems represent a long-established history of dual-wavelength Er:YAG (2940 nm) and Nd:YAG (1064 nm) optical engineering.

Founded in 1964 and headquartered in Ljubljana, Slovenia, Fotona is one of the oldest laser developers in the world, tracing its roots to early defense and industrial optical research before transitioning to medical and aesthetic lasers.

An analysis of the openFDA MAUDE (Manufacturer and User Facility Device Experience) database shows that Fotona holds an unusually small safety record: only 8 reports submitted under manufacturer "Fotona" (consisting of 6 Injury reports, 1 Other, and 1 unspecified event type, with zero Death reports and zero Malfunctions). Adverse events are scattered across the SP Dynamis, NightLase, and gynecological tissue systems. There are zero FDA recalls associated with Fotona in the historical database.

It is important to clarify that popular patient-facing treatments such as Fotona 4D (non-surgical laser facelift), SmoothEye (periocular rejuvenation), and NightLase (snoring reduction) are not distinct FDA-cleared devices; rather, they are clinical treatment protocols delivered using the dual-wavelength laser modules of the cleared SP Dynamis console.

---

How many FDA 510(k) clearances does Fotona hold, and what is the Fidelis, Dualis, LightWalker, SP Dynamis lineage?

Regulatory Clearance Analysis

An audit of the FDA’s Premarket Notification 510(k) registry shows that Fotona has secured 38 clearances.

Unlike many competitors who file across a dozen different product codes, all 38 of Fotona's clearances are registered under the primary product code GEX (Powered Laser Surgical Instrument). This reflects Fotona's focus on optical laser consoles that incorporate Er:YAG and Nd:YAG laser resonators within a single chassis.

The Product Line Lineage

Fotona's technological evolution flows through three distinct product clusters:

1. Multi-Application Path (SkinPlus to Dynamis Pro):

   • SkinPlus (K980560, 1998) established the high-power Nd:YAG baseline.
   • Dualis Nd:YAG/Er:YAG (K011939, 2001) introduced dual-wavelength integration.
   • Fidelis III (K070355, 2008) added variable pulse control and articulated delivery arms.
   • SP Dynamis (K101306, 2011) established the flagship dual-wavelength platform.
   • Dynamis Pro Family (K213267, 2022) updated user interfaces, foot-controls, and pulse structures.

2. Compact & specialized Path (LightWalker to XPulse Pro):

   • LightWalker AT/DT (K101817, 2010) optimized dual wavelengths for dental and surgical uses.
   • StarWalker (K171227, 2017) developed high-peak nanosecond pulses for pigmented lesions.
   • SkyPulse (K193656, 2020) created a compact, targeted Er:YAG console.
   • XPulse Pro (K202991, 2021) integrated multiple diode wavelengths for minor surgical procedures.

The Early Lineage (1998–2009)

Fotona introduced European erbium and Nd:YAG designs to the US market in the late 1990s:

• SkinPlus Laser System (K980560, 1998-03-27): Fotona's first US clearance, introducing a high-power Nd:YAG laser for hair removal and vascular coagulation.
• Fidelis Er:YAG (K990243, 1999-06-09 & K001527, 2000-07-27): Established Fotona's dental and dermatological Er:YAG (2940 nm) technology, focusing on precise, water-targeted tissue ablation.
• Dualis Nd:YAG/Er:YAG (K011939, 2001-12-27 & K021548, 2002-12-06): Fotona’s first dual-wavelength system, combining erbium and Nd:YAG resonators in a single console. This design allowed clinicians to switch between superficial ablation and deep thermal coagulation.
• Fidelis III Er:YAG/Nd:YAG (K070355, 2008-03-04): Consolidated the dual-wavelength design with digital pulse-width control and an articulated arm delivery system.

The SP Dynamis and Dynamis Pro Lineage (2010–Present)

The Dynamis series represents Fotona's flagship multi-application aesthetic platforms:

• SP Dynamis (K101306, 2011-07-01 & K143723, 2015-04-09): The baseline multi-application console. It featured a high-power Er:YAG laser (2940 nm) and a long-pulsed Nd:YAG laser (1064 nm).
• Dynamis Pro Family (K213267, 2022-09-08): The current flagship system, updating the internal optical path, implementing wireless footswitch control, and refining pulse delivery configurations.

The LightWalker and Compact Platform Lineage (2010–Present)

Parallel to the SP Dynamis, Fotona developed high-repetition dental and specialized laser systems:

• LightWalker AT/DT (K101817, 2010-11-22 & K242202, 2024-08-23): Dual-wavelength laser systems optimized for dental hard-tissue ablation and soft-tissue surgical procedures, while maintaining compatibility with dermatological handpieces.
• StarWalker (K171227, 2017-08-18 & K202172, 2020-11-19): A Q-switched laser incorporating "Active Q-Switching" technology. It delivers high-peak-power nanosecond pulses (under product code GEX) for tattoo removal and deep dermal pigmentation.
• SkyPulse (K193656, 2020-03-27) & XPulse Pro (K202991, 2021-06-22): Compact, tabletop Er:YAG and diode platforms designed for targeted applications in dental, ENT, and light-based facial rejuvenation.

---

What is Fotona 4D, SmoothEye, and NightLase, and are they FDA-cleared devices or treatment protocols?

A common point of confusion among both providers and patients is the regulatory status of popular Fotona treatments. None of these terms refer to individual machines cleared by the FDA; they are proprietary clinical treatment protocols performed using the SP Dynamis or Dynamis Pro dual-wavelength platforms.

The primary protocols are:

• Fotona 4D is a non-surgical facelift protocol consisting of four distinct steps: SmoothLiftin, FRAC3, PIANO, and SupErficial.
• SmoothEye is a periocular skin tightening protocol using Er:YAG in non-ablative Smooth mode.
• NightLase is a snoring reduction protocol targeting the soft palate mucosa using Er:YAG.

1. The Fotona 4D Protocol (Non-Surgical Facelift)

Fotona 4D is a four-step treatment designed to address facial laxity, skin texture, and volume loss without down-time. It leverages the different absorption profiles of Er:YAG (water-absorbing, superficial) and Nd:YAG (hemoglobin/protein-absorbing, deep) wavelengths:

• Step 1: SmoothLiftin (Intraoral Er:YAG): Delivered from inside the oral cavity. Using a non-ablative Er:YAG mode (Smooth mode), the laser delivers controlled heat to the mucosal lining of the cheeks and lips. This heats the deep collagen fibers of the mid-face to 60–65°C, inducing immediate collagen contraction and tightening the nasolabial folds from the inside out.
• Step 2: FRAC3 (Fractional Nd:YAG): Delivered externally. The Nd:YAG laser is fired in a short, sub-millisecond pulse width. This targets micro-vascular structures and pigmented irregularities in the dermis, creating a fractional pattern of thermal injury that stimulates neocollagenesis while leaving the surrounding tissue unaffected.
• Step 3: PIANO (Deep Nd:YAG Heating): Uses a long, ultra-second pulse width (seconds, not milliseconds). The Nd:YAG laser is swept continuously over the face to heat the deep dermis and subcutaneous tissues to 42–45°C. This bulk heating stimulates collagen remodeling and skin tightening.
• Step 4: SupErficial (Light Er:YAG Peel): A light ablative Er:YAG sweep over the skin’s surface. This removes the dead stratum corneum cells, improving skin texture and giving the skin a refreshed appearance.

2. The SmoothEye Protocol

SmoothEye focuses on the delicate periocular region. It utilizes the non-ablative Smooth mode Er:YAG laser to heat the target tissue of the upper and lower eyelids. This stimulates collagen tightening around the eyes to address fine lines, laxity, and under-eye bags with minimal recovery time.

3. The NightLase Protocol (Snoring Reduction)

NightLase is a non-invasive treatment for snoring. The clinician uses an Er:YAG handpiece to deliver Smooth mode pulses to the mucosal tissues of the soft palate, uvula, and tonsillar pillars:

• Mechanism: The energy heats the collagen in the oral mucosa to approximately 60°C, causing the tissue to contract and firm.
• Clinical Goal: Tightening the soft palate tissue opens the airway at the back of the throat, reducing the tissue vibrations that cause snoring.
• Regulatory Note: In the US, the SP Dynamis is cleared for the ablation and coagulation of oral mucosa (K101306). Performing NightLase falls within this cleared surgical scope, though it is typically marketed as a specialized clinical protocol.

For details on how these skin tightening methods compare to energy devices like Ultherapy or Thermage, see our comparison of ultrasound and RF skin tightening platforms.

---

Fotona 4D Protocol: Clinical Parameters and Wavelength Physics

The success of the Fotona 4D protocol lies in the precise configuration of laser pulse modalities. Below are the standard clinical parameters used on the SP Dynamis Pro console:

• Step 1: SmoothLiftin (Intraoral Mucosa): Wavelength 2940 nm (Er:YAG), Handpiece PS03, Smooth Mode, Frequency 1.5–2.0 Hz, Pulse Width 250 ms (train of 5 pulses), Energy 7.5–10 J/cm², Spot size 7 mm. Perform 3 to 4 passes over the intraoral mucosa of the cheeks and lips.
• Step 2: FRAC3 (Dermal Remodeling): Wavelength 1064 nm (Nd:YAG), Handpiece R33, FRAC3 mode (0.3 ms pulse duration), Frequency 3–5 Hz, Fluence 15–20 J/cm², Spot size 4 mm. Perform 2 to 3 sweeps over the face to target superficial vessels and pigmented irregularities.
• Step 3: PIANO (Bulk Dermal Heating): Wavelength 1064 nm (Nd:YAG), Handpiece R33, PIANO mode (6-second brush pulse duration), Fluence 60–90 J/cm² (delivered continuously), Spot size 9 mm. Sweep the handpiece over facial zones using a thermal camera to monitor skin surface temperature, maintaining a target temperature of 42–45°C for 3 minutes per zone.
• Step 4: SupErficial (Light Ablation): Wavelength 2940 nm (Er:YAG), Handpiece PS03, MSP mode (Short Pulse - 100 microseconds), Frequency 2–3 Hz, Fluence 2.0–3.0 J/cm², Spot size 7 mm. Perform 1 pass over the entire face to create a light micro-exfoliation.

---

NightLase Snoring Protocol: Target Tissues and Energy Settings

The NightLase protocol utilizes non-ablative Er:YAG laser energy to induce mucosal collagen remodeling, widening the upper airway:

• Target Tissue Mapping: The treatment grid is mapped over the soft palate, uvula, anterior and posterior faucial pillars, and the base of the tongue.
• Equipment Specs: Handpiece PS03 (collimated 7 mm spot), Wavelength 2940 nm.
• Energy Parameters: Smooth mode, Frequency 1.6 Hz, Pulse train of 5 pulses, Energy density 1.5–2.0 J/cm².
• Clinical Passes: Deliver 5 to 6 passes over the entire mapped area, delivering approximately 8,000 to 10,000 cumulative pulses. The tissue should show mild, transient edema and erythema without mucosal ablation or bleeding.
• Treatment Schedule: 3 sessions performed at days 1, 15, and 45. Annual maintenance sessions are recommended to maintain collagen elasticity.

---

Technical Head-to-Head: Fotona SP Dynamis vs. Sciton Joule Er:YAG

Clinics evaluating high-end Er:YAG resurfacing systems should understand how Fotona's flagship platform compares to Sciton's Joule (profiled in our Sciton footprint article):

Design Differences

• Variable Square Pulse (VSP) vs. Tunable Pulse Width: Fotona's VSP technology controls the shape of the laser pulse, generating a square-wave pulse that prevents the energy tail seen in standard Nd:YAG and Er:YAG systems. This reduces unwanted thermal energy delivery to surrounding tissue, improving safety margins. Sciton's Tunable Pulse Width allows the operator to select the ratio of ablation to coagulation manually, providing high versatility but requiring advanced clinical training.
• The Optoflex Arm: Fotona utilizes an articulated mechanical arm with mirror joints (Optoflex) to deliver the 2940 nm wavelength. Since 2940 nm light is absorbed by silica glass, it cannot travel through standard optical fibers. Sciton utilizes specialized hybrid fiber cables or mechanical arms depending on the handpiece module.

---

What is Fotona's current aesthetic laser portfolio?

The following table profiles Fotona's active product line cleared for distribution in the United States:

---

What does the MAUDE safety profile and recall record show for Fotona, and why is it unusually clean?

Adverse Event Analysis

An analysis of the FDA’s openFDA MAUDE database under manufacturer name "Fotona" yields 8 total reports. The distribution of these events is highly structured:

• Injury Reports: 6 cases.
• Other/Unclassified: 1 case.
• Unspecified event type (NaN): 1 case.
• Death Reports: 0 cases.
• Malfunction-Only Reports: 0 cases.

The total count of 8 reports over nearly three decades of market presence represents an unusually small safety record for a major global laser manufacturer. For comparison, other major laser manufacturers with similar market size often show between 50 and 200 reports in the MAUDE registry.

Brand-Specific Breakdown

The 8 reports in the database are divided among the following system categories:

• Fotona SP Dynamis / SP Dinamis: 3 reports (labeled "FOTONA SP DYNAMIS", "FOTONA SP DINAMIS", and "SP DYNAMIS"). The reports describe minor epidermal burns and post-treatment hyperpigmentation during external facial treatments.
• NightLase: 1 report (labeled "FOTONA NIGHTLASE LASER"). This report involves localized swelling and mucosal discomfort following a snoring treatment.
• Vaginal Tightening Systems: 1 report (labeled "FONTONA LASER FOR VAGINAL TIGHTENING"). This report describes temporary mucosal discomfort.
• General / Legacy Systems: 3 reports (labeled "FOTONA", "LARES RESEARCH/FOTONA", and "DYNAMIS PRO FAMILY"). These involve early Nd:YAG hair removal burns or minor blistering.

Why is Fotona's MAUDE Profile Unusually Clean?

Several factors explain Fotona’s low adverse event count:

1. Er:YAG Physics: Fotona's skin-tightening and intraoral protocols rely heavily on Er:YAG lasers operating in Smooth mode. Because Er:YAG has a water absorption rate that is 10 times higher than CO2 lasers, the energy is absorbed in the most superficial layers of the skin, reducing the risk of deep thermal burns.
2. Pulse Control (VSP Technology): Fotona utilizes Variable Square Pulse (VSP) technology, which controls the shape of the laser pulse to avoid energy spikes that can cause sudden tissue heating.
3. European Manufacturing Standards: Fotona design and assembly take place in Ljubljana, Slovenia, under European medical device guidelines, which emphasize mechanical and optical stability.
4. Device-Only Reporting Focus: Unlike some manufacturers whose databases are filled with minor user errors or clinical complaints, Fotona's safety profile reflects a focus on reporting significant, verified device-related injuries.

Recall History

A search of the FDA’s Enforcement Reports registry shows zero active or historical recalls issued under recalling firm "Fotona" or naming "SP Dynamis", "LightWalker", "StarWalker", or "NightLase" systems. This indicates a consistent manufacturing record and a lack of systemic mechanical or software defects.

For comparisons with other laser safety profiles, see our footprint articles on Sciton and Lutronic.

---

Clinical Trial Evidence

Fotona's clinical safety and efficacy are documented in a registered trial on ClinicalTrials.gov, supplemented by protocol-level clinical literature:

• NCT03962621 (Combined Er:YAG/Nd:YAG Facial Rejuvenation): A randomized, factorial-design interventional trial evaluating the combined Er:YAG (2940 nm) and Nd:YAG (1064 nm) system for facial skin rejuvenation. The study enrolled 20 subjects, with imaging-based assessment (Visia CR) as the registered primary outcome. The trial is listed as completed; quantitative efficacy and patient-satisfaction results were not posted to the public registry.
  • Method: The treatment protocol combines intraoral Smooth-mode Er:YAG (Step 1 of Fotona 4D) with external long-pulsed Nd:YAG (Step 3 PIANO).
• NightLase (Snoring-Reduction Protocol): NightLase is a non-ablative Er:YAG clinical protocol — not a separately cleared device — for reducing snoring. Its efficacy is documented in peer-reviewed otolaryngology literature rather than a Fotona-sponsored interventional trial registered on ClinicalTrials.gov.
• Gynecological / Vaginal Rejuvenation Protocols: Fotona's Smooth-mode Er:YAG protocols (e.g., IntimaLase) are offered clinically, but providers should note the FDA's public communications cautioning against marketing energy-based devices for unapproved cosmetic vaginal rejuvenation. These are clinical protocols rather than independently cleared devices.

---

The 1964 Slovenian Laser Legacy: From Military Defense to Medical Aesthetics

Fotona's position in the aesthetic laser market is tied to the history of laser development in Slovenia. The company was founded in 1964 in Ljubljana, then part of the Socialist Federal Republic of Yugoslavia.

• The Iskra Military Research Roots: Fotona grew out of the research divisions of the Iskra Electro-Chemical Group and the Jožef Stefan Institute. Following the invention of the laser in 1960, the Yugoslav defense department sought to develop domestic laser rangefinders, target designators, and industrial welding optics. Fotona was established to manufacture these high-precision optical components.
• Pioneering Medical Lasers: In the late 1970s and early 1980s, Fotona redirected its optical engineering divisions toward medicine. The company developed its first medical laser, a CO2 system, in 1982, followed by dental Er:YAG lasers in the early 1990s.
• Global Expansion and Private Transition: Following the independence of Slovenia in 1991, Fotona transitioned from a state-owned enterprise to a private corporation, focusing on the medical and aesthetic markets. Today, the company operates as a global developer, with all manufacturing, optical coating, and software engineering remaining at its central facility in Ljubljana, Slovenia, maintaining a 60-year engineering heritage.

---

FAQ: Common Provider and Patient Questions

Is Fotona 4D an FDA-cleared device, and what laser does it use?

No, Fotona 4D is not an individual machine cleared by the FDA. It is a four-step clinical treatment protocol performed using the Fotona SP Dynamis or Dynamis Pro console. The platform is FDA-cleared under product code GEX. The protocol utilizes two wavelengths: an ablative/non-ablative Er:YAG laser (2940 nm) and a long-pulsed Nd:YAG laser (1064 nm) to treat the skin from both the intraoral mucosal surface and the external skin surface.

Does NightLase for snoring have FDA clearance, and what does the safety data show?

The SP Dynamis laser platform is FDA-cleared for the incision, excision, ablation, vaporization, and coagulation of oral soft tissue (K101306). Performing the NightLase snoring reduction protocol falls within this cleared surgical scope. The safety data in the openFDA MAUDE registry is small, showing only one report of transient mucosal swelling and discomfort, indicating that when performed by a trained provider, the protocol has a high safety profile.

What is the difference between SP Dynamis and SP Spectro?

The SP Dynamis is the full-power console, configured with a high-power Er:YAG laser (2940 nm) and a high-power Nd:YAG laser (1064 nm). The SP Spectro is a compact version of the platform, utilizing the same software interface and handpieces but configured with lower peak power outputs, which can result in slightly longer treatment times for bulk-heating protocols like PIANO.

How does the intraoral step of Fotona 4D work?

The intraoral step (SmoothLiftin) targets the buccal mucosa inside the cheeks. The Er:YAG laser operates in a non-ablative Smooth mode, delivering rapid train pulses that heat the deep mucosal tissue to approximately 60–65°C without vaporizing the surface tissue. This temperature triggers immediate collagen contraction and stimulates new collagen production, helping to lift and tighten the lower face and reduce the appearance of nasolabial folds.

Can Fotona lasers be used safely on skin of color?

Yes. Unlike many light-based systems, Fotona’s PIANO mode Nd:YAG (1064 nm) laser features low melanin absorption, making it safe for bulk heating in Fitzpatrick skin types IV–VI. Additionally, the Smooth mode Er:YAG laser delivers energy in a non-ablative, controlled manner that reduces the risk of post-inflammatory hyperpigmentation (PIH) compared to traditional ablative CO2 lasers. However, conservative energy settings and proper pre-treatment assessments remain critical for managing thermal risk in darker skin phototypes.

---

Sources

1. FDA 510(k) K213267 (Dynamis Pro Family): FDA Premarket Notification Database Entry.
2. FDA 510(k) K101306 (SP Dynamis): FDA Premarket Notification Database Entry.
3. FDA 510(k) K242202 (LightWalker Family): FDA Premarket Notification Database Entry.
4. FDA 510(k) K202172 (StarWalker): FDA Premarket Notification Database Entry.
5. ClinicalTrials.gov Study NCT03962621: A Study of the Efficacy of Erbium:YAG 2940nm in Combination With 1064nm Laser on Facial Rejuvenation. ClinicalTrials.gov Entry.
6. Fotona Corporate History: 60 Years of Laser Innovation. Fotona About Us.
7. openFDA MAUDE Database Portal: Manufacturer "Fotona" search query. openFDA MAUDE Portal.
8. Journal of the Laser and Health Academy: Variable Square Pulse (VSP) Technology in Aesthetic Medicine. LAHA Publications Archive.